The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Yay it’s going up a bit ??!!
Ok but when is thisten day deadline? I hope we do hear soon. This defo needs a rerate
I do not think there is any leak, maybe a dodgy shorting attack or distressed seller, Im hopeful this wont happen again now. As far as FDA, FBDU as per NICK S interview said they have worked closely with FDA to make enhancements to the application so getting FDA approval shouldnt be an issue. I also took a few more on today's dip. You dont pay the COO £100K if you dont think there is mileage here and given tex rad is being used by GE healthcare already its a good route in.
Does anyone here still any idea why this happened today. I thought 2 p was stable ? Any leaks on fda ?? What’s going on ?
I know Franco, Isn't it Ironic ? (alanis Morisette)
I hope so too
well whatever it was it has brought in lots of buyers and interest, hopefully at the right time
weve seen the back of the seller, was a great top up opportunity, maybe see the delayed sells later
Looks more like a fishing trip to me but WTFDIK
It was dropped to fill a big buy order and at the same time some t i t panicked and sold :-)
I added, if you look the clever people like Mad Stork added
2 million buys x 400k sells ... could be a BIG order is being filled ... or someone peanut confectionery brand is trying to frick with our minds ..
-- BB --
Why are we dipping again ?
yeah possibly the new COO
It wasn't me but I was more than happy to take advantage of the dip.
think it was taken down to fill that big buy order
Yes TB is very communicative, a good person to have on the board.
if David Smith was in the placing at 2.5p or if he still to pick up shares. Would be interesting if goes over 3%. To get in now is a bit of a steal ahead of the FDA approval for the kidney product. Dont forget this is a main market share.
GE is the partner in Asia.
FBDU 6 Aug 2018 RNS: Holding: Kathleen Schmainda- Threshold crossed from 5.49% to 7.59% holding in FBDU.
[See icon RNS above this page].
Kathleen Schmainda- Linkedin [Public Open File]
"Vice Chair, Radiology Reserch, Medical College of Wisconsin: 2011 to Present."
"Education: MIT: PhD Electrical & Medical Engineering & Harvard Medical School"
"Patent: Method for detecting tumour cell invasion using short diffusion times."
"Groups: Magnetic Resonance"
Link: https://www.linkedin.com/in/kahleen-schmainda-35437814
From MCW.Edu site: "Kathleen Schmainda: PhD, Professor of Radiology & Biophysics, Imaging Science, Research Radiology.
From Grantome: "Quantative {Perfusion & Diffusion} MRI Biomarkers to measure Giloma Response: Kathleen Schmainda.
Please check. DYOR.
draft
I just happened to see the Flying Brands video interview on Twitter. I thought it would be educational. So just out of curiosity, I watched the interview. I follow Mayo Clinic and one or two other American hospitals of renown. So, when I heard the mention of Mayo Clinic, I was interested. I also think that it is helpful to patients & surgeons to be able to see where the tumour ends and where the inflamation starts per the interview. So, I have been slowly going through what I heard and following through. In general, I have to acquaint myself further as to the general market in medical imaging. I am not in the medical profession hence I have to do research layer by layer.
this could be very interesting
draft
I dont normally post on any forum that I have not bought in in general - but not today. I try to do a lot of research before I buy in but it is not a large position. I try as much as possible to delve more deeply but not done it thoroughly yet. Courtesy of a reply. Kind regards.
News. Thur 23 Aug 2018
whats your position here, have you bought in then?
P.S.
From the FBDU 1 Aug 2018 Prospectus
Left out: Biometric Imaging at a NUMBER of hospitals & clinics.
draft
Thank you for mentioning about the latest Flying Brands Prospectus. I have managed to read quite a bit from the 109 pages.
Flying Brands 1 Aug 2018 Prospectus [109 pgs] www.flyingbrands.co.uk/publications/
1)In essence, there are 3 BioMetrics products: IB Neuro, IB Diffusion & IB DCE
The IB DCE does a WHOLE BODY approach used to monitor BREAST cancer, PROSTRATE cancer & BRAIN Cancer.
In May BioMetrics was installed full suite at the General Anti-Cancer & Oncology Hospital in Athens, Greece.
Pg 40- It was said that Biometrics is in luminary centres eg MAYO CLINIC & Barrow Neurological Institute, Arizona, USA.
It has been in PEER-REVIEWED PUBLICATIONS supporting the product. There are 3,700 active neurological surgeons.
Accelerating the sale of Imaging. Next generation....
1)STONECHECKER- "Aims to be standard medical imaging software for urolithiasis."
Comment: So not just brain but as above. Please check as there can be copying / typo errors. DYOR.